Indication
Heparin-induced Thrombocytopenia
3 clinical trials
3 products
Product
VLX-1005Clinical trial
A Phase I, Open-Label, Randomized, Three-Period, Three-Sequence Crossover Study of the Effects of Co-administration of Intravenous VLX-1005 With Argatroban on Pharmacokinetics, Pharmacodynamics and Safety in Healthy Adult SubjectsStatus: Completed, Estimated PCD: 2022-04-01
Product
ArgatrobanClinical trial
Open-Label, Randomised, Active Controlled, Multi-Centre Ph 3 Study to Evaluate the Safety and Efficacy of Danaparoid vs Argatroban in Acute HITStatus: Terminated, Estimated PCD: 2022-06-10
Product
Danaparoid SodiumClinical trial
Characterization and Quantification of Platelet/Leukocyte Aggregates in Patients With Suspected Heparin-induced ThrombocytopeniaStatus: Recruiting, Estimated PCD: 2026-04-01